Hematology-OncologyAsparaginaseChidamide
Navigating Dual Resistance in Extranodal NK/T-Cell Lymphoma: Challenges and Emerging Insights
By MedXY|Jul 15, 2026
Dual resistance to asparaginase and PD-1 inhibitors in extranodal NK/T-cell lymphoma leads to poor prognosis; chidamide-containing regimens show promising survival benefits in this difficult-to-treat population.